Dualistic Roles of High Mobility Group Box 1 in Cancer and Inflammation
Cancer Medicine · 2025-12 · 14 (23)
DOI: 10.1002/cam4.71455 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, online erschienen am 07.12.2025. Verfasst von Wen Zeng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, People's Republic of China. Hauptthemen laut MEDLINE: HMGB1 Protein, Neoplasms, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Department of Science and Technology.
Themen: Mobilisation
Abstract (Originalsprache)
Background
The High Mobility Group Box 1 (HMGB1) protein, a member of the HMG family, plays a crucial role in both cancer progression and inflammatory responses. HMGB1 can act as a damage‐associated molecular pattern (DAMP) to activate immune responses and modulate inflammation. Its dualistic roles in promoting and inhibiting tumor growth, as well as its involvement in DNA repair and drug resistance, make it a key target for understanding and treating cancer and inflammatory diseases.
Objective
This review aims to explore the dualistic roles of HMGB1 in cancer and inflammation, focusing on its pro‐inflammatory and anti‐inflammatory functions in the tumor microenvironment, its impact on DNA damage repair and tumor drug resistance, and its potential as a therapeutic target for cancer and inflammatory diseases.
Methods
We conducted a comprehensive review of the literature on HMGB1, analyzing its structural features, biological functions, and mechanisms of action in various pathological contexts. We also examined the impact of HMGB1 on tumor progression, immune responses, and metabolic reprogramming in cancer cells, as well as its role in inflammatory signaling pathways.
Results
HMGB1 exhibits both oncogenic and tumor‐suppressive effects in cancer. It promotes tumor growth, metastasis, and immune evasion through mechanisms such as shaping the tumor microenvironment, driving metabolic reprogramming, and inducing drug resistance. Conversely, HMGB1 can enhance anti‐tumor immunity by activating dendritic cells and T cells. In inflammation, HMGB1 acts as a DAMP, activating immune responses via receptors like RAGE and TLR4. Its redox state and subcellular localization determine its proinflammatory or anti‐inflammatory functions. Targeting HMGB1 has shown promise in preclinical and clinical studies, with potential applications in anti‐cancer and anti‐inflammatory therapies.
Conclusion
The dualistic roles of HMGB1 in cancer and inflammation highlight its complexity and potential as a therapeutic target. Future research should focus on elucidating the context‐specific mechanisms of HMGB1, developing precision‐targeted therapies to modulate its multifunctional activities, and translating these findings into clinical practice to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, People's Republic of China.
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning Province, People's Republic of China.
- Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, People's Republic of China.
ORCID-Profile: Wen Zeng, Xiaohong Du, Leifeng Chen
Förderung
- National Natural Science Foundation of China
- Jiangxi Provincial Department of Science and Technology
Zitieren
APA
Zeng, W., Zhang, X., Jiang, Y., Luo, Y., Wang, Z., Du, X., & Chen, L. (2025). Dualistic Roles of High Mobility Group Box 1 in Cancer and Inflammation. Cancer Medicine, 14(23). https://doi.org/10.1002/cam4.71455
Vancouver
Zeng W, Zhang X, Jiang Y, Luo Y, Wang Z, Du X, et al. Dualistic Roles of High Mobility Group Box 1 in Cancer and Inflammation. Cancer Medicine. 2025;14(23). doi:10.1002/cam4.71455
BibTeX
@article{Zeng2025,
author = {Zeng, Wen and Zhang, Xu and Jiang, Yulu and Luo, Yuxiang and Wang, Zuao and Du, Xiaohong and Chen, Leifeng},
title = {Dualistic Roles of High Mobility Group Box 1 in Cancer and Inflammation},
journal = {Cancer Medicine},
year = {2025},
volume = {14},
number = {23},
doi = {10.1002/cam4.71455}
}
EUVIMED